Autocrine glutamate signaling promotes glioma cell invasion.
about
Perspectives in Intraoperative Diagnostics of Human GliomasThinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signalingGlutamate and tumor-associated epilepsy: glial cell dysfunction in the peritumoral environmentGlial cells in (patho)physiologySLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant gliomaEstablishment and Characterization of a Tumor Stem Cell-Based Glioblastoma Invasion ModelIDH mutations in tumorigenesis and their potential role as novel therapeutic targets.Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosisThe role of metabotropic glutamate receptor 5 on the stromal cell-derived factor-1/CXCR4 system in oral cancerHigh-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma CellsBradykinin promotes the chemotactic invasion of primary brain tumorsClinical considerations and surgical approaches for low-grade gliomas in deep hemispheric locations: insular lesions.Glioblastoma cells express functional cell membrane receptors activated by daily used medical drugs.Phosphoinositide 3-kinases upregulate system xc(-) via eukaryotic initiation factor 2α and activating transcription factor 4 - A pathway active in glioblastomas and epilepsyRole of glutamate transporters in redox homeostasis of the brain.Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas.Molecular interaction and functional regulation of ClC-3 by Ca2+/calmodulin-dependent protein kinase II (CaMKII) in human malignant glioma.Inhibition of the Sodium-Potassium-Chloride Cotransporter Isoform-1 reduces glioma invasion.KCa3.1 modulates neuroblast migration along the rostral migratory stream (RMS) in vivo.Downregulation of cystine transporter xc by irinotecan in human head and neck cancer FaDu xenografts.Glutamate and its receptors in cancerSystem xc⁻ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS.The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities.Identification of a novel set of genes reflecting different in vivo invasive patterns of human GBM cells.Calpain 2 is required for glioblastoma cell invasion: regulation of matrix metalloproteinase 2.Overexpression of calcium-permeable glutamate receptors in glioblastoma derived brain tumor initiating cells.Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor-kappaB.Apoptosis imaging for monitoring DR5 antibody accumulation and pharmacodynamics in brain tumors noninvasively.Synergistic inhibition of survival, proliferation, and migration of U87 cells with a combination of LY341495 and Iressa.Ion channels and transporters [corrected] in cancer. 2. Ion channels and the control of cancer cell migrationGlutamate secretion and metabotropic glutamate receptor 1 expression during Kaposi's sarcoma-associated herpesvirus infection promotes cell proliferation.Glutamate release by primary brain tumors induces epileptic activityCortical GABAergic excitation contributes to epileptic activities around human glioma.The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells.Regulation of system x(c)(-)activity and expression in astrocytes by interleukin-1β: implications for hypoxic neuronal injuryCalpain 2 is required for the invasion of glioblastoma cells in the zebrafish brain microenvironment.Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.Extracellular human immunodeficiency virus type 1 viral protein R causes reductions in astrocytic ATP and glutathione levels compromising the antioxidant reservoir.Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma.Overview of Glutamatergic Dysregulation in Central Pathologies.
P2860
Q26778788-7CFA52EB-361C-43D9-AC5C-58181676EF9CQ26864995-B103C407-B797-4B15-8A55-BFA1E8F04AD4Q27011499-6B752E79-E7FB-4D07-AEAC-FDCC2A86E5C9Q27021135-D5A32BD1-E0F1-4826-874A-D3209B6D18AAQ27325399-A0FA53AB-1DE2-480A-88E4-D41CE371D049Q27333230-B59EFF3F-FFE3-4772-ABE4-0F181DEC85CCQ27692015-43DCF77D-0DA3-4AE6-8195-90003212741FQ28066155-5024A0D5-9973-456F-868D-87B30D2F0C6AQ28535088-7C060AD1-7592-4352-8F20-9DA647A70F42Q28547125-B9D8BF9F-53BC-49B4-9E9D-0A1E5508688DQ30500283-E8834377-D52D-4DFD-A81B-3EB3EA66516CQ31132607-E35C8B91-D0DB-4A34-A174-1D30C876C124Q33471536-2673D16A-ED03-4837-A57A-A8BFDA1CDEF9Q33687799-192318EE-F757-4791-B5E1-B9F28A8BDBB1Q33758360-0E832D59-61C0-43E4-8195-B5853254A340Q33759231-10890E4B-E71A-44F1-815E-A72CD6EC1213Q33799622-8C474B01-1374-4DA8-95E8-658B2259C496Q33959036-BAE3E377-5C46-4114-B358-77639E90EBAAQ34027793-FC63E900-06BB-4F25-92EB-CA3604424065Q34038268-996F8593-560B-4F3A-BB75-73929D1DE9A7Q34048497-4C9E9961-6AF8-4F13-BA89-283207331B7DQ34184493-875E67CC-4E9E-4A9B-8885-49489D94A213Q34279067-135D0D14-3091-4FBE-BB05-1C5E4940D482Q34383355-E5BBDF6C-E579-47D2-A119-F05CDD38DA10Q34425717-FEF71074-77C1-4AD0-A8D8-695463C1175EQ34460630-3D15B796-2ED7-4542-9DD7-8D03DA01663DQ34543666-3F403B2B-3969-4252-ABBB-5D18BECD3FC8Q34728592-5A92841A-90D1-46D8-87F6-CDDE3D56D91FQ34749647-C06C36B0-2D87-4F7B-9C5B-A663442E5E63Q35216836-E22B2E3D-5567-4A97-A403-536FC523C1E1Q35315503-E8E0D15E-FF2E-441A-B384-F1833E06279FQ35331983-73C6D933-628A-4016-BC23-DDC59D8D9453Q35535883-60E61E58-F2A7-49F1-83F4-AFAE7C407A39Q35633662-BE951F16-65F5-46FE-8A9C-91A66AE791BEQ35672546-F5FC2929-4943-40D6-9EAF-73C7FFB48662Q35742619-0F62C8B1-3897-4920-8E7B-C2C6EDC7DD6BQ35927273-1BD14897-50F8-4EA3-A399-C7353BC4B809Q36098705-FD53D6DD-F074-4B13-8458-A5F87E7166E6Q36347143-FA6E90AE-0BEA-44F7-9DF4-0E60CCD9FFDBQ36409596-51ACB647-6E90-479D-8C83-AA46870589B4
P2860
Autocrine glutamate signaling promotes glioma cell invasion.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Autocrine glutamate signaling promotes glioma cell invasion.
@ast
Autocrine glutamate signaling promotes glioma cell invasion.
@en
type
label
Autocrine glutamate signaling promotes glioma cell invasion.
@ast
Autocrine glutamate signaling promotes glioma cell invasion.
@en
prefLabel
Autocrine glutamate signaling promotes glioma cell invasion.
@ast
Autocrine glutamate signaling promotes glioma cell invasion.
@en
P2093
P2860
P1433
P1476
Autocrine glutamate signaling promotes glioma cell invasion
@en
P2093
Amy K Weaver
Toyin Ogunrinu
W Joon Chung
P2860
P304
P356
10.1158/0008-5472.CAN-07-2034
P407
P577
2007-10-01T00:00:00Z